Stay updated with breaking news from Increases Osteogenesis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lund, December 15, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that preclinical data on its candidate drug tasquinimod, a small molecule immunomodulator, are now available on the
Lund, November 4, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that two abstracts with new preclinical data on tasquinimod, a small molecule immunomodulator, have been accepted for presentation
Investegate announcements from Active Biotech, New preclinical data on tasquinimod will be presented at the annual meeting of American Society of Hematology (ASH)